Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

GenOdyssee's novel natural interferon variant GEA-007.1 shows improved activity against HCV

Oct. 30, 2006

Priority review for Humira in moderate to severely active Crohn's disease

Oct. 30, 2006

Libivirumab/exbivirumab suppresses HBV breakthrough in liver transplant patients

Oct. 30, 2006

Genetic polymorphisms linked to atazanavir toxicity

Oct. 30, 2006

Preclinical advance for ChronVac-C administered using MedPulser delivery system

Oct. 27, 2006

FDA approves Tyzeka for chronic hepatitis B

Oct. 26, 2006

Phase II study of HCV-796 begins dosing

Oct. 26, 2006

New Nexium formulation approved by FDA

Oct. 25, 2006

PDL BioPharma and ECCO collaborate to support visilizumab program

Oct. 25, 2006

MEFV found to be a disease susceptibility gene for IBD

Oct. 24, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....